Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 14 (HMGB1P14) is a member of the HMGB1-related pseudogene family. Pseudogenes are DNA sequences similar to known genes but are not translated into functional proteins because of accumulated mutations or deletions. While many pseudogenes, including HMGB1P14, are not protein coding and lack direct biological or disease-related roles, some recent studies suggest that certain pseudogenes can participate in the regulation of their parent genes at the RNA level through competitive endogenous RNA mechanisms or other forms of gene expression modulation. As of current knowledge, HMGB1P14 has not been established as having a functional role and is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 14 (HMGB1P14).